Inactive Instrument
BiVictriX Therapeutics plc Share Price
Stocks
BVX
GB00BNXH3K91
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +17.65% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
CEO | Chief Executive Officer | 39 | 31/12/2015 |
Adrian Howd
DFI | Director of Finance/CFO | 54 | 02/10/2023 |
Alison Halsall
SEC | Corporate Secretary | - | 12/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
BRD | Director/Board Member | 39 | 31/12/2015 |
Susan Lowther
BRD | Director/Board Member | 67 | 21/09/2021 |
William Paris
BRD | Director/Board Member | 75 | 21/09/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/09/24 | Buy | Director | 20,000 | 0.0242% | ||
| 02/09/24 | Sell | Director | 20,000 | 0.0242% | ||
| 13/08/24 | Free | Executive/Senior Manager | 320,000 | 0.3878% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +17.65% | +33.33% | - | - | 10.49M | |
| +0.65% | -3.36% | +36.98% | +60.50% | 64.14B | |
| +2.08% | +3.80% | +13.48% | +85.92% | 55.53B | |
| +1.84% | +2.07% | +13.37% | +105.84% | 53.03B | |
| -0.37% | -1.01% | +26.47% | +55.51% | 45.99B | |
| +0.60% | -2.30% | +18.62% | +100.14% | 42.45B | |
| +1.07% | +0.52% | +225.17% | +928.15% | 40.45B | |
| +0.64% | -3.95% | +11.15% | +45.57% | 32.25B | |
| +0.25% | +45.97% | +108.39% | +94.58% | 34.47B | |
| -2.72% | -0.44% | +23.18% | -10.77% | 24.23B | |
| Average | +2.18% | +4.08% | +52.98% | +162.83% | 43.62B | |
| Weighted average by Cap. | +0.70% | +3.49% | +49.94% | +160.70% |
Employees
-
